Lv4
468 积分 2022-02-14 加入
Number Needed to Treat
1天前
已关闭
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous Nephropathy
10天前
已关闭
Empagliflozin-associated Armanni-Ebstein lesions in IgA nephropathy
10天前
已完结
Clinical phenotype and prognosis of Patients with Diabetic Kidney Disease complicated by a Primary Podocytopathy
11天前
已关闭
Mitochondrial protein TOMM7 alleviates diabetic kidney disease by regulating mitophagy via intracellular redistribution of phospholipase PLA2G6
13天前
已完结
Proteogenomic dissection of kidney disease and cardiovascular-kidney-metabolic syndrome
24天前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
Optimal patient care in advanced chronic kidney disease progressing to kidney failure
1个月前
已关闭
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?
1个月前
已完结
皖公网安备34019202002308
